Division of Pediatric Blood & Marrow Transplantation- Research

PUBLICATIONS RESEARCH STUDIES MASONIC CANCER CENTER CLINICAL TRIALS

"We dare to suggest we can transform the practice of medicine... because we've done it before... many times."

—John Wagner, MD, Director, University of Minnesota Pediatric Blood and Marrow Transplant program

Our team within the Division of Blood and Marrow Transplantation (BMT) is focused on the integral relationship between clinical care and research. With world-class expertise, a culture of cross-disciplinary collaboration, and a proven track record of successfully bringing therapies from the lab to patients, our physicians and researchers are leading the field in developing treatments and cures for childhood cancers and rare diseases. We continue to break new ground in a variety of areas. We are leaders in alternative stem cell therapies, umbilical cord blood transplantation and immune-based therapies. We also provide novel treatment options for patients with rare, life-threatening conditions and work tirelessly to reduce transplant side effects and improve quality of life for patients after transplant. Our research is focused in three areas:

Finding treatments and cures for the incurable
Making transplant more successful
Improving the long-term health and outcomes for our patients

Dr. Stefanski Researchers in the Transplant Biology and Therapy program collaborate closely with scientists from the University of Minnesota's Masonic Cancer Center, Stem Cell Institute and Medical School. Our groundbreaking research has led to the development of treatments for leukemia, lymphoma, inherited genetic diseases, immune disorders and hemoglobinopathies.

We continue to push the boundaries of science to increase the understanding of pediatric cancers and other diseases that can be treated with blood and marrow transplantation (BMT). Together, we challenge the status quo and help to change the practice of medicine.